BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19369341)

  • 1. Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells.
    Vatakis DN; Kim S; Kim N; Chow SA; Zack JA
    J Virol; 2009 Jun; 83(12):6222-33. PubMed ID: 19369341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding HIV latency to undo it.
    Cohen J
    Science; 2011 May; 332(6031):786. PubMed ID: 21566174
    [No Abstract]   [Full Text] [Related]  

  • 5. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.
    Manganaro L; Lusic M; Gutierrez MI; Cereseto A; Del Sal G; Giacca M
    Nat Med; 2010 Mar; 16(3):329-33. PubMed ID: 20173753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope.
    Agosto LM; Yu JJ; Liszewski MK; Baytop C; Korokhov N; Humeau LM; O'Doherty U
    J Virol; 2009 Aug; 83(16):8153-62. PubMed ID: 19493998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early transcription from nonintegrated DNA in human immunodeficiency virus infection.
    Wu Y; Marsh JW
    J Virol; 2003 Oct; 77(19):10376-82. PubMed ID: 12970422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
    Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
    J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
    Plesa G; Dai J; Baytop C; Riley JL; June CH; O'Doherty U
    J Virol; 2007 Dec; 81(24):13938-42. PubMed ID: 17928354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.
    Bukrinsky MI; Stanwick TL; Dempsey MP; Stevenson M
    Science; 1991 Oct; 254(5030):423-7. PubMed ID: 1925601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
    Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
    J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation.
    Tang S; Patterson B; Levy JA
    J Virol; 1995 Sep; 69(9):5659-65. PubMed ID: 7637012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.
    Sahu GK; Lee K; Ji J; Braciale V; Baron S; Cloyd MW
    Virology; 2006 Nov; 355(2):127-37. PubMed ID: 16919704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
    Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.
    Vatakis DN; Bristol G; Wilkinson TA; Chow SA; Zack JA
    J Virol; 2007 Apr; 81(7):3574-82. PubMed ID: 17229711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear landscape of HIV-1 infection and integration.
    Lusic M; Siliciano RF
    Nat Rev Microbiol; 2017 Feb; 15(2):69-82. PubMed ID: 27941817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid expression of human immunodeficiency virus following activation of latently infected cells.
    Arlen PA; Brooks DG; Gao LY; Vatakis D; Brown HJ; Zack JA
    J Virol; 2006 Feb; 80(3):1599-603. PubMed ID: 16415036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
    Tardif MR; Tremblay MJ
    J Virol; 2005 Nov; 79(21):13714-24. PubMed ID: 16227291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.
    Levine BL; Mosca JD; Riley JL; Carroll RG; Vahey MT; Jagodzinski LL; Wagner KF; Mayers DL; Burke DS; Weislow OS; St Louis DC; June CH
    Science; 1996 Jun; 272(5270):1939-43. PubMed ID: 8658167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.